New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
10:01 EDTCSGP, TSQ, TKMR, SYRG, SBLK, SMI, SEAS, PFNX, MVNR, MELA, XENT, IMDZ, STAY, EPAM, DSGX, CTSO, VTSSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: CoStar Group (CSGP) initiated with a Buy at Goldman... CytoSorbents (CTSO) initiated with a Buy at H.C. Wainwright... Descartes Systems (DSGX) initiated with an Overweight at Barclays... EPAM Systems (EPAM) initiated with a Sell at Monness Crespi... Extended Stay America (STAY) resumed with an Overweight at JPMorgan... Immune Design (IMDZ) initiated with a Buy at Jefferies... Intersect ENT (XENT) initiated with an Outperform at Leerink... MELA Sciences (MELA) initiated with a Buy at H.C. Wainwright... Mavenir Systems (MVNR) coverage resumed with a Buy at BofA/Merrill... Pfenex (PFNX) initiated with a Buy at Mizuho... SeaWorld (SEAS) initiated with an Outperform at Credit Suisse... Semiconductor Manufacturing (SMI) initiated with an Overweight at Barclays... Star Bulk Carriers (SBLK) initiated with an Overweight at Evercore... Synergy Resources (SYRG) initiated with a Buy at Canaccord... Tekmira (TKMR) initiated with an Outperform at Leerink... Townsquare Media (TSQ) initiated with a Buy at BofA/Merrill... Vitesse (VTSS) initiated with an Outperform at Northland.
News For CSGP;CTSO;DSGX;EPAM;STAY;IMDZ;XENT;MELA;MVNR;PFNX;SEAS;SMI;SBLK;SYRG;TKMR;TSQ;VTSS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 30, 2014
16:44 EDTTKMRTekmira up 12% after hours following CDC confirmation of Ebola case in U.S.
14:27 EDTSEASSeaWorld hires top DC lobbying firm, The Hill says
SeaWorld hired a "powerhouse" DC lobbying firm, according to The Hill. The firm will discuss issues involving the display, research and public education of marine mammals with federal officials, the website quoted SeaWorld as saying in forms. Reference Link
10:02 EDTEPAMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:33 EDTSYRGSynergy Resources reaches peak production rate of 8,700 BOED in August
Subscribe for More Information
06:46 EDTEPAMEPAM Systems initiated with a Positive at Susquehanna
Target $51.
September 26, 2014
09:58 EDTCTSOCytoSorbents management to meet with Brean Capital
Subscribe for More Information
07:47 EDTTKMREMA to review BioCryst, Sarepta, Tekmira experimental Ebola medicines
Subscribe for More Information
07:32 EDTPFNXBioCentury to hold a conference
21st Annual NewsMakers in the Biotech Industry Conference to be held in New York on September 26.
September 25, 2014
06:41 EDTTKMRTekmira volatility flat on wide price movement
Subscribe for More Information
September 23, 2014
07:38 EDTDSGXCantor to hold a conference
3rd Annual Technology Conference to be held in Toronto on September 23.
06:45 EDTSTAYExtended Stay America growth underappreciated, says Barclays
Subscribe for More Information
06:27 EDTTSQTownsquare Media management to meet with Jefferies
Subscribe for More Information
06:13 EDTTKMRTekmira to collaborate with international consortium researching Ebola
Subscribe for More Information
September 22, 2014
14:46 EDTTSQTownsquare Media acquires XXL, King and Antenna from Harris Publications
Townsquare Media announced that it has acquired the iconic hip hop brand XXL, along with King and Antenna from Harris Publications, a special interest media company. These well-known properties will join Townsquare Media’s category-leading national digital portfolio of over 20 premium multi-platform brands including Taste of Country, PopCrush, Just Jared, Hype Machine, ScreenCrush, Loudwire and The Boombox. Following the October edition of XXL magazine, due to hit newsstands in early October, the magazine will cease regular publication in order to focus exclusively on digital operations as well as special editions of the publication in the future. As part of the transactions, all members of the XXL team will be joining Townsquare Media
13:02 EDTTKMRTekmira surges on FDA authorization of TKM-Ebola for emergency use
Subscribe for More Information
12:57 EDTTKMRTekmira up 20% following FDA authorization of TKM-Ebola for emergency use
09:16 EDTTKMRTekmira establishes regulatory framework for emergency use of TKM-Ebola
Subscribe for More Information
08:28 EDTXENTIntersect ENT announces RESOLVE clinical study met primary safety endpoints
Intersect ENT announced initial results from RESOLVE, a clinical study of the company's investigational steroid eluting implant designed to treat patients with recurrent sinus obstruction in the office setting. The study met its primary safety endpoints, with 100% implant placement success and no serious adverse events. In addition, initial data compiled through the first 90 days of the six-month study demonstrated: Statistically significant reductions in clinicians' endoscopic scoring of bilateral nasal polyp burden and ethmoid sinus obstruction in the treatment group, as compared to the control group through 90 days. Clinically meaningful, two-fold greater improvement in patient symptoms measured by nasal obstruction/congestion score for the treatment group, as compared to controls at 90 days. This difference was statistically significant for patients who had a higher polyp burden at baseline. At 90 days, 52% of patients in the treatment arm were no longer indicated for sinus surgery, compared with 22% of the patients in the control arm, demonstrating a clinically meaningful reduction in the need for revision surgery.
September 19, 2014
10:43 EDTSBLKStar Bulk Carriers files to sell 29.9M shares for selling shareholder
September 18, 2014
07:23 EDTMELACraig-Hallum to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use